Skip to main content
logo
Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
14.50
+0.28 (1.97%)
At close: Nov 12, 2025, 4:00 PM EST
14.40
-0.10 (-0.69%)
After-hours: Nov 12, 2025, 5:23 PM EST

Embecta Revenue

Embecta had revenue of $295.50M in the quarter ending June 30, 2025, with 8.44% growth. This brings the company's revenue in the last twelve months to $1.10B, down -1.47% year-over-year. In the fiscal year ending September 30, 2024, Embecta had annual revenue of $1.12B with 0.21% growth.

Revenue (ttm)
$1.10B
Revenue Growth
-1.47%
P/S Ratio
0.76
Revenue / Employee
$525,000
Employees
2,100
Market Cap
848.03M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 20241.12B2.30M0.21%
Sep 30, 20231.12B-8.70M-0.77%
Sep 30, 20221.13B-35.80M-3.07%
Sep 30, 20211.17B79.80M7.35%
Sep 30, 20201.09B-23.50M-2.12%
Sep 30, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

EMBC News

More News